Optimizing Aging Male Symptom Questionnaire Through Genetic Algorithms Based Machine Learning Techniques
- PMID: 32009307
- PMCID: PMC7752504
- DOI: 10.5534/wjmh.190077
Optimizing Aging Male Symptom Questionnaire Through Genetic Algorithms Based Machine Learning Techniques
Abstract
Purpose: Genetic algorithm (GA) is a machine learning optimization strategy where sample strategies compete for fitness to evolve an optimum solution. This study evolves the Aging Male Symptoms (AMS) with GA to better identify late onset hypogonadism (LOH) with serum testosterone.
Materials and methods: GA was trained on a training set of standard AMS questionnaire on a nationwide LOH epidemiology study. Random matrices of selectors for particular items were generated. Each generation of was evolved through a fitness function determined by sensitivity. Threshold to determine positive serum testosterone level for LOH was randomized for each competing strategy. After 2,000 runs, with each run producing the best result out of a set of 3,000 randomly generated sets evolved through 300 generations, the best AMS selection matrix was then applied to a separately enrolled validation set to compare outcomes.
Results: Predictability for serum testosterone levels dropped markedly above 3.5 ng/mL during pilot training. Limiting the training to testosterone thresholds between 2.5 and 3.5 ng/mL the GA 93 different strategies. Only a selection of 5 items, determining for a threshold of 20 points and determining for a serum testosterone level of 3.16 ng/mL, showed robust reproducibility within the internal validation set. Applying these conditions to the independent validation set showed sensitivity improved from 0.66 to 0.77, with a specificity of 0.07 to 0.19, respectively.
Conclusions: GA method of selecting questionnaires improved AMS questionnaire significantly. This method can be easily applied to other questionnaires that do not correlate with physiological markers.
Keywords: Hypogonadism; Machine learning; Questionnaire design; Testosterone.
Copyright © 2021 Korean Society for Sexual Medicine and Andrology.
Conflict of interest statement
The authors have nothing to disclose.
Figures
References
-
- Dobs AS. The role of accurate testosterone testing in the treatment and management of male hypogonadism. Steroids. 2008;73:1305–1310. - PubMed
-
- Taniguchi H, Kawa G, Kinoshita H, Matsuda T. Change of aging males' symptoms (AMS) rating scale in Japanese late-onset hypogonadism (LOH) patients administered androgen replacement therapy. J Men Health. 2011;8:S67–S70.
-
- Lunenfeld B, Saad F, Hoesl CE. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Aging Male. 2005;8:59–74. - PubMed
-
- Kong XB, Guan HT, Li HG, Zhou Y, Xiong CL. The ageing males' symptoms scale for Chinese men: reliability,validation and applicability of the Chinese version. Andrology. 2014;2:856–861. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
